Treatment-Experienced
Showing 9976 - 10000 of >10,000
500 "Normal" Adult Experienced no Known Brain Injury Will
Not yet recruiting
- Cranial Waveform in Normal Patients as a Result of Cardiac Cycle
- Healthy
- Harmony Headset
-
Cupertino, CaliforniaMindRhythm Incorporated
Jan 10, 2022
Chronic Pain Trial (Cognitive Behavioral Therapy (CBT), Hypnotic Cognitive Therapy (HYP-CT), Mindfulness-Based Cognitive Therapy
Not yet recruiting
- Chronic Pain
- Cognitive Behavioral Therapy (CBT)
- +2 more
- (no location specified)
Jan 23, 2023
Cerebrovascular Stroke, Upper Extremity Paresis Trial in United Kingdom, United States (Paired Vagus Nerve Stimulation,
Completed
- Cerebrovascular Stroke
- Upper Extremity Paresis
- Paired Vagus Nerve Stimulation
- Rehabilitation
-
Scottsdale, Arizona
- +19 more
Jul 11, 2022
Lupus Erythematosus, Systemic Trial in China (JMKX000189, Placebo)
Recruiting
- Lupus Erythematosus, Systemic
- JMKX000189
- Placebo
-
Bengbu, Anhui, China
- +16 more
Jul 30, 2023
Regarding Glucose Metrics, Sleep, and Health Economics
Completed
- Type 1 Diabetes
- Tandem Control-IQ
-
Kungsbacka, Region Of Halland, SwedenThe hospital of Halland Kungsbacka
Jul 28, 2023
Pancreatic Cancer Non-resectable Trial (collection of blood and tumor samples)
Not yet recruiting
- Pancreatic Cancer Non-resectable
- collection of blood and tumor samples
- (no location specified)
Mar 27, 2023
HIV/AIDS Trial in Chicago (LINK2 Youth Services Navigation Intervention)
Active, not recruiting
- HIV/AIDS
- LINK2 Youth Services Navigation Intervention
-
Chicago, IllinoisUniversity of Chicago
Nov 18, 2022
Healthy Trial in Daejeon (LivaloV, A, LivaloVA)
Completed
- Healthy
- LivaloV
- +2 more
-
Daejeon, Korea, Republic ofClinical Trial Center, Chungnam National University Hospital
Aug 9, 2022
Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder Trial in Hamilton (50:2 mg(CBD:THC)/ml - Cannabinoid Oil
Withdrawn
- Generalized Anxiety Disorder
- +3 more
- 50:2 mg(CBD:THC)/ml - Cannabinoid Oil Oral Preparation- titrated as tolerated up to a maximum 8mls twice daily (200 mg- 800 mg total dose)
- Placebo Oil
-
Hamilton, Ontario, CanadaMacAnxiety Research Centre
Mar 22, 2021
Non Small Cell Lung Cancer (NSCLC), Metastases to the Brain Trial in Pittsburgh (cabozantinib)
Terminated
- Non Small Cell Lung Cancer (NSCLC)
- Metastases to the Brain
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Cancer Institute- Hillman Cancer Center
Mar 8, 2021
Body Weight, Body Fat, Overweight Trial (Vigiis 101 Lactobacillus Capsules, Placebo Capsules)
Not yet recruiting
- Body Weight
- +2 more
- Vigiis 101 Lactobacillus Capsules
- Placebo Capsules
- (no location specified)
May 18, 2023
Positilonal Deformation of the Skull, Head Turn Preference, Axial Hypertony Trial in Montpellier (manual therapy/osteopathy)
Completed
- Positilonal Deformation of the Skull
- +2 more
- manual therapy/osteopathy
-
Montpellier, Hérault, FranceCHU Arnaud de Villeneuve
Dec 13, 2022
Educational Interventions for Surgeons During COVID-19 Pandemic:
Unknown status
- COVID-19
- Cross sectional e-Survey on surgeons exposed to any educational intervention
-
Créteil, FranceAssistance Publique Hôpitaux de Paris - GHU AP-HP Hôpitaux Unive
Feb 6, 2021
Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination
Not yet recruiting
- Elderly AML Patients
- +4 more
- Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
- Active Comparator: Standard dose of Venetoclax + Azacitidine
-
Kunming, Yunnan, ChinaThe Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023
Depressive Disorder, Treatment-Resistant Trial in Saint Louis (tDCS)
Active, not recruiting
- Depressive Disorder, Treatment-Resistant
- tDCS
-
Saint Louis, MissouriWashington University in Saint Louis
Jul 27, 2022
Medically Unexplained Symptoms Trial in New Haven (Parent training)
Recruiting
- Medically Unexplained Symptoms
- Parent training
-
New Haven, ConnecticutYale Child Study Center, Yale University School of Medicine
Aug 31, 2021
Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 2, 2022
Learn More About Order of Different Treatments and Their Effects
Not yet recruiting
- Metastatic Colorectal Cancer
- Regorafenib (Stivarga, BAY73-4506)
- (no location specified)
Nov 13, 2023
Obesity, Pregnancy Related Trial in Pittsburgh (HABITpreg, HABITpost)
Active, not recruiting
- Obesity
- Pregnancy Related
- HABITpreg
- HABITpost
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Feb 1, 2023
Liver Failure, Acute on Chronic, Hepatic Encephalopathy, HBV Trial in Guangzhou (Rifaximin 200 mg, Standard Treatment without
Recruiting
- Liver Failure, Acute on Chronic
- +5 more
- Rifaximin 200 mg
- Standard Treatment without Rifaximin
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Mar 26, 2023
Biomechanical- and AI- Based Rehabilitation Strategies for Pain
Not yet recruiting
- Healthy
- Degenerative Disease
-
Seongnam, Korea, Republic of
- +1 more
Jun 6, 2023
Aortic Isthmus Stenosis Trial in Erlangen
Recruiting
- Aortic Isthmus Stenosis
-
Erlangen, GermanyClinical Research Center, Department of Nephrology and Hypertens
Jun 6, 2023
Forward Head Posture Trial in Lahore (Diaphragmatic Breathing Exercise Group, Thoracic Extension Exercise Group)
Recruiting
- Forward Head Posture
- Diaphragmatic Breathing Exercise Group
- Thoracic Extension Exercise Group
-
Lahore, Punjab, PakistanRiphah Rehabilitation Clinic
Nov 15, 2023